Key Quantitative Figures
Standalone Financial Performance (H1 FY27 vs H1 FY26):
- Total Income: ₹4,782.05 lakhs (vs ₹3,913.65 lakhs)
- Revenue from Operations: ₹4,045.99 lakhs (vs ₹3,304.57 lakhs)
- Other Income: ₹736.06 lakhs (vs ₹609.08 lakhs)
- Net Profit: ₹995.19 lakhs (vs ₹566.14 lakhs)
- Basic & Diluted EPS: ₹17.77 (vs ₹10.11)
Consolidated Financial Performance (H1 FY27 vs H1 FY26):
- Total Income: ₹4,816.50 lakhs (vs ₹3,955.07 lakhs)
- Revenue from Operations: ₹4,053.05 lakhs (vs ₹3,331.05 lakhs)
- Other Income: ₹763.45 lakhs (vs ₹624.02 lakhs)
- Net Profit: ₹1,042.26 lakhs (vs ₹565.24 lakhs)
- Basic & Diluted EPS: ₹18.61 (vs ₹10.09)
Quarterly Standalone Results (Q2 FY27 vs Q2 FY26):
- Total Income: ₹2,330.45 lakhs (vs ₹1,923.15 lakhs)
- Net Profit: ₹271.31 lakhs (vs ₹167.57 lakhs)
- Basic & Diluted EPS: ₹4.84 (vs ₹2.99)
Balance Sheet Position (Standalone as at September 30, 2026):
- Total Assets: ₹23,423.56 lakhs
- Equity Share Capital: ₹560.06 lakhs
- Other Equity: ₹20,073.03 lakhs
- Current Assets: ₹18,563.76 lakhs
- Non-Current Assets: ₹4,859.80 lakhs
Subsidiary Restructuring Decision
The Board reconsidered its previous decision from September 18, 2026 meeting and approved:
1. Conversion of all Optionally Convertible Preference Shares (OCPS) held in Stellent Chemicals Industries Limited (Wholly Owned Subsidiary) into Equity Shares
2. Subsequent divestment/transfer of entire Equity Shareholding (including converted shares) to another Wholly Owned Subsidiary, Dinesh Felts Limited (formerly Fernway Technologies Limited)
3. This replaces the previous plan to divest/transfer Equity Shares and OCPS separately
Entities Involved
- Parent: Shri Dinesh Mills Limited
- Subsidiaries: Dinesh Felts Limited, Stellent Chemicals Industries Limited
- Step-down Associate: McGean India Chemicals Private Limited (associate of Stellent Chemicals)
- Statutory Auditors: Dhirubhai Shah & Co. LLP
Additional Financial Information
Discontinued Operations:
Dinesh Remedies Limited ceased to be subsidiary effective September 3, 2025. For H1 FY25, discontinued operations showed:
- Total Income: ₹623.21 lakhs
- Total Expense: ₹669.93 lakhs
- Loss after tax: ₹(46.72) lakhs
Exceptional Items:
Represent adjustments for voluntary retirement and loss on sale of investment in subsidiary during reportable periods.
Cash Flow Statements:
Standalone H1 FY27:
- Operating Activities: ₹(663.67) lakhs
- Investing Activities: ₹1,069.18 lakhs
- Financing Activities: ₹(31.43) lakhs
- Net Increase in Cash: ₹374.08 lakhs
Consolidated H1 FY27:
- Operating Activities: ₹(675.40) lakhs
- Investing Activities: ₹991.77 lakhs
- Financing Activities: ₹(31.45) lakhs
- Net Increase in Cash: ₹284.92 lakhs
Dates and Timing
- Board Meeting: October 26, 2026 (5:00 PM to 6:00 PM)
- Financial Period: Quarter and Half Year ended September 30, 2026
- Auditor Review Date: October 26, 2026
Governance Details
- Chairman & Managing Director: Bharat Patel (DIN: 00039543)
- Company Secretary & Compliance Officer: J B Sojitra (Membership No: A-6351)
- Statutory Auditor: Dhirubhai Shah & Co. LLP (FRN: 102511W/W100298)